Diagnostic screening programs help catch cancer, abnormalities or other diseases before they reach an advanced stage, saving lives and healthcare costs. Screening programs include, lung, breast, prostate, and cervical cancer, among many others.
Ultrasound is routinely used to screen for HCC. However, its utility is limited by numerous factors, including patient body habitus, operator experience and certain liver conditions, all of which contribute to decreases in sensitivity.
In conjunction with prevention efforts, the introduction of screening examinations has resulted in a reduction of nearly 6 million cancer-related deaths since 1975.
Breast density is most often discussed within the context of cancer risk, but new research suggests that it also could be used as a marker of cardiometabolic health.
The newly cleared offering, AutoChamber, was designed with opportunistic screening in mind. It can evaluate many different kinds of CT images, including those originally gathered to screen patients for lung cancer.
Blue Cross and Blue Shield of Texas (BCBSTX) has developed electronic patient clinical summaries for its health plan members displaced by Hurricane Rita.
The Joint Commission on Accreditation of Healthcare Organizations (JCAHO) has created an advisory panel on information technology to help reengineer the delivery of care to improve safety, quality and efficiency.
Touting new "true isotropic resolution to oncology," Toshiba America Medical Systems today announced U.S. shipments of the Aquilion LB, which received FDA clearance in March.
Royal Philips Electronics has announced the release of an enhancement to the professional document creation platform SpeechMagic enabling for the first time adequate speech recognition in Citrix environments.
iCAD Inc. has announced the broadening of its technology partnership with TeraRecon Inc., a provider of advanced image processing and 3D visualization techniques.
The Swedish IT and medical technology company Sectra has announced the formation of a long-term strategic alliance with Australian-based Kestral Computing Pty Ltd.
RBMA President Peter Moffatt discusses declining reimbursement rates, recruiting challenges and the role of artificial intelligence in transforming the industry.
Deepak Bhatt, MD, director of the Mount Sinai Fuster Heart Hospital and principal investigator of the TRANSFORM trial, explains an emerging technique for cardiac screening: combining coronary CT angiography with artificial intelligence for plaque analysis to create an approach similar to mammography.
A total of 16 cardiology practices from 12 states settled with the DOJ to resolve allegations they overbilled Medicare for imaging agents used to diagnose cardiovascular disease.
